For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Suspected case of Meningococcal Disease prompts reminder
Suspected case of Meningococcal Disease prompts reminder

A suspected case of Meningococcal Disease in New Plymouth has prompted a reminder from Taranaki DHB Medical Officer of Health, Dr Greg Simmons for our community to be vigilant for signs and symptoms of the disease.
Dr Simmons says, “At this current time, the Taranaki District Health Board does not believe this case poses an increased risk to the community. However, Meningococcal Disease can be very serious and people should be reminded of the signs and symptoms of the disease.”
Meningococcal disease can progress very quickly and may initially appear as a flu-like illness. The signs and symptoms of Meningococcal Disease can include any of the following:
• High temperatures (fever)
• Headache
• Confusion and sleepiness
• Joint pain, aching muscles and/or neck stiffness
• Dislike of bright lights
• Vomiting
• Red or purple skin rash
If an individual is sick, check them often. Don’t delay to seek medical attention by either:
• Ringing the 24/7 Healthline – 0800 611 611
• Visiting your GP
• Visiting Medicross or Phoenix Urgent Doctors
• Visiting the hospital’s Emergency Departments (ED) More information can also be found at http://www.moh.govt.nz/meningococcal